"The natural question is, how would DeepSeek's emergence impact compute intensity growth and the demand for ...

Fortune 500 companies are increasingly looking beyond their walls to bring in top-tier financial leadership, marking a shift ...

External hiring of finance chiefs hit a 10-year high in 2024, according to Crist Kolder Associates' annual report.

Anat Ashkenazi. Potential risks and negatives for the stock encompassed a loss of search volumes due to increasing usage of ChatGPT, Meta AI and, others; an unfavorable remedy ruling in the search ...

Eli Lilly cut its 2024 revenue guidance, saying demand for its obesity and diabetes drugs had not met its lofty expectations. Eli Lilly expects about $3.5 billion in revenue for its diabetes ...

Eli Lilly and Company (NYSE:LLY) announced on Tuesday that the pharmaceuticals company expects Q4 2024 revenue to be ~$13.5B. The consensus revenue estimate stands at $13.95B. "While the U.S ...

Eli Lilly (LLY) shares traded down more than 6% Tuesday after the company reported revenue guidance for the fourth quarter of 2024 that missed Wall Street expectations. Lilly revised its revenue ...

Eli Lilly and Company (LLY) is a global leader in healthcare innovation, specializing in discovering, developing, and delivering life-changing medicines to address some of the world's most pressin ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other best blue chip stocks to buy for 2025. Both conservative and risk-tolerant investors ...